ASCO-Genitourinary Cancers Symposium 2023 Conference Feb 16-18 Feb 16 - Feb 18, 2023 Supporting Materials Lorigerlimab (PD-1 × CTLA-4) Phase 1 Study Expansion Data in Patients with mCRPC 847.6 KB
